BIOCATALYSTS LIMITED

Their core work

Biocatalysts Limited is a Cardiff-based SME specializing in enzyme discovery, development, and manufacturing for industrial applications. They contribute enzyme expertise to EU projects focused on greener consumer products — from splitting triglycerides in bio-based processes to engineering oxidoreductases for textiles, cosmetics, detergents, and nutraceuticals. Their role sits at the intersection of protein engineering and industrial biotechnology, turning lab-scale enzyme concepts into commercially viable biocatalytic solutions.

What they specialise in

How they've shifted over time

Their early H2020 work (2016, LIPES) focused on a specific bioprocess application — enzymatic triglyceride splitting — suggesting a traditional enzyme supplier role. By 2021, their involvement shifted dramatically toward computational and high-throughput enzyme discovery, with RADICALZ bringing in machine learning, metagenomics, and microfluidics, while OXIPRO added supercomputing and in silico design. The trajectory shows a company moving from applying known enzymes to actively discovering and engineering new ones using digital tools.

Biocatalysts is investing heavily in AI-driven and computational enzyme design, positioning itself as a partner for projects that need rapid, data-driven biocatalyst development rather than traditional screening.

How they like to work

Biocatalysts operates exclusively as a contributor rather than a project leader — zero coordinator roles across three projects, with two participations and one third-party involvement. They work within large consortia (36 unique partners across 14 countries), suggesting they are sought after as a specialized enzyme provider that slots into bigger research initiatives. Their third-party role in RADICALZ indicates they are sometimes brought in for specific technical capabilities rather than full consortium membership.

Despite only three projects, Biocatalysts has built a surprisingly broad network of 36 unique partners spanning 14 countries, reflecting their participation in large multi-partner consortia rather than tight bilateral collaborations. Their network is pan-European with no obvious geographic concentration.

What sets them apart

Biocatalysts occupies a rare niche as a commercial enzyme company that bridges academic enzyme research and industrial product development. Unlike university labs that publish but don't manufacture, or large chemical companies that buy but don't discover, they can both engineer and produce enzymes at scale. Their recent pivot toward machine learning and computational design makes them particularly valuable for projects that need to move quickly from enzyme concept to working prototype.

Highlights from their portfolio

• LIPES
  Their largest funded project (EUR 305,940), focused on enzymatic triglyceride splitting — core to their foundational bioprocessing expertise.
• OXIPRO
  Combines supercomputing, responsible research (RRI), and circularity goals to create an oxidoreductase foundry for greener consumer products across textiles, cosmetics, and detergents.
• RADICALZ
  Demonstrates their shift toward high-throughput enzyme discovery using machine learning, metagenomics, and microfluidics — a BBI-IA-DEMO project signaling close-to-market ambition.